HKEX:2096 - Simcere Pharmaceutical Group Ltd

Simcere Pharmaceutical Group L
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2019 Q2	2019 Q4	2020 Q2	2020 Q4	2021 Q2	2021 Q4	2022 Q2	2022 Q4	2023 Q2	2023 Q4	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	2.88B 36.0%	2.7B -6.3%	3.62B 34.3%	3.38B -6.8%	3.23B -4.5%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	10.16B 2.3%	9.94B -2.2%	10.79B 8.5%	12.69B 17.6%	10.85B -14.5%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	3.7B -13.4%	3.79B 2.4%	3.64B -3.9%	3.64B -0.1%	3.63B -0.1%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	6.44B 14.2%	6.13B -4.8%	7.13B 16.4%	9.05B 26.9%	7.22B -20.2%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	320.86M -	685M 113.5%	669.1M -2.3%	-82.03M -	233.08M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	1.28B -60.7%	973.14M -24.2%	1.87B 91.7%	1.66B -11.1%	2.45B 47.6%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	973.14M -24.1%	1.87B 91.7%	1.66B -11.1%	2.45B 47.5%	2.01B -18.0%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	111.37M -	559.53M 402.4%	116.57M -79.2%	-295.29M -	-533.52M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	949.28M 70.4%	63.78M -93.3%	867.08M 1259.4%	2.27B 162.3%	-1.56B -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	0.37 76.4%	0.02 -94.6%	0.34 1600.0%	0.86 152.9%	-0.6 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-